Angela Gwaltney

Angela Gwaltney is a research scientist in the Genomics, Ethics, and Translation group in RTI’s genomic-focused Omics Center. Her current research delves into genotype-phenotype correlations, psychometric analyses, and statistical examination of behavioral data across various rare genetic disorders, including Angelman Syndrome (AS), Rett Syndrome, FMR1 disorders, and Severe Combined Immunodeficiency (SCID). Dr. Gwaltney has extensive experience in harnessing diverse datasets, including patient- and clinician-reported, administrative, and survey data, to design, analyze, and execute both prospective and retrospective analyses. Her contributions have led to the identification of clinical outcome assessments deemed crucial by caretakers and clinicians, and demonstrate sensitivity to change over time and in response to interventions. Dr. Gwaltney has also conducted studies on patient experiences, unmet needs, and treatment preferences, which have been used to develop resources and assistance for families navigating the complexities of a rare genetic disorder diagnosis through the newborn screening system.

Before joining RTI in 2018, Dr. Gwaltney was a doctoral researcher at the University of North Carolina at Chapel Hill, where she examined psychotropic medication use and outcomes in the child welfare population through cross-sectional and longitudinal data analysis.